This map shows the geographic impact of Nissenson Ar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nissenson Ar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nissenson Ar more than expected).
This network shows the impact of papers produced by Nissenson Ar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nissenson Ar. The network helps show where Nissenson Ar may publish in the future.
Co-authorship network of co-authors of Nissenson Ar
This figure shows the co-authorship network connecting the top 25 collaborators of Nissenson Ar.
A scholar is included among the top collaborators of Nissenson Ar based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Nissenson Ar. Nissenson Ar is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
17 of 17 papers shown
1.
Johnson, David W., et al.. (2014). Working toward changes in nephrology practice.. PubMed. 28(3). 16–16.1 indexed citations
Mehrotra, Rajnish, David Marsh, Петерс, & Nissenson Ar. (2003). Emphasizing patient choice: the modality selection project in ESRD Network 18.. PubMed. 17(12). 30–6.
5.
Ar, Nissenson, et al.. (2003). L-carnitine use in dialysis patients: is national coverage for supplementation justified? What were CMS regulators thinking--or were they?. PubMed. 17(5). 28–30, 32.5 indexed citations
6.
Eknoyan, Garabed, et al.. (2001). NKF and RPA collaborating on clinical practice guidelines for chronic kidney disease.. PubMed. 15(8). 13, 54–13, 54.2 indexed citations
7.
Ar, Nissenson, et al.. (2000). The current and future state of the ESRD program: a provider roundtable.. PubMed. 20(6). 543–55.3 indexed citations
8.
Ar, Nissenson, et al.. (1999). Peritoneal dialysis case forum. Necrotizing panniculitis in a morbidly obese patient with end-stage renal disease.. PubMed. 18(5). 546–53.2 indexed citations
9.
Ar, Nissenson. (1998). Nephrology in the future.. PubMed. 12(4). 35–7.2 indexed citations
Ar, Nissenson. (1991). National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group.. PubMed. 18(4 Suppl 1). 24–33.30 indexed citations
16.
Ar, Nissenson. (1989). Recombinant human erythropoietin: impact on brain and cognitive function, exercise tolerance, sexual potency, and quality of life.. PubMed. 9(1 Suppl 2). 25–31.47 indexed citations
17.
Ar, Nissenson. (1980). Prevention of dialysis-induced hypoxemia by bicarbonate dialysis.. PubMed. 26. 339–42.27 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.